PubRank

J D Rosenblatt

Author PubWeight™ 61.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science 1989 3.00
2 Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 1989 2.67
3 Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature 1986 2.49
4 The x gene is essential for HTLV replication. Science 1985 2.44
5 A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986 1.44
6 Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989 1.36
7 Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 1994 1.33
8 Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn 1999 1.29
9 Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997 1.22
10 Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene 1989 1.22
11 Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 1998 1.21
12 Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 1999 1.15
13 Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991 1.12
14 A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol 1987 1.07
15 Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood 1993 1.06
16 Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5'long terminal repeat. Virology 1991 1.04
17 Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol 1995 1.03
18 In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes. J Virol 1989 1.03
19 Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol 1991 1.03
20 Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes 1996 1.02
21 Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res 1999 0.99
22 Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element. J Virol 1991 0.99
23 Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol 2001 0.97
24 In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci 1999 0.95
25 Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem 1997 0.95
26 Ectopic skeletal muscles derived from myoblasts implanted under the skin. J Cell Sci 1998 0.94
27 Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther 1997 0.94
28 HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene 1992 0.91
29 Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation. J Virol 1996 0.89
30 Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer. Clin Colorectal Cancer 2001 0.89
31 Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein. AIDS Res Hum Retroviruses 1998 0.87
32 A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther 2003 0.87
33 Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leuk Lymphoma 1994 0.87
34 Slow axonal regrowth but extreme hyperinnervation of target muscle after suture of the facial nerve in aged rats. Neurobiol Aging 1998 0.86
35 Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer 1990 0.85
36 A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme. Hum Gene Ther 1999 0.85
37 Lentiviral vectors and gene therapy. Front Biosci 1999 0.84
38 Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood 1999 0.83
39 Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood 1993 0.83
40 A colony assay for in vitro transformation by human T cell leukemia viruses type I and type II. Blood 1987 0.82
41 A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway. J Immunol 1998 0.81
42 Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function. Virology 1994 0.81
43 Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene 1995 0.81
44 Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis. Leukemia 2003 0.80
45 The rheumatoid factor reactivity of a human IgG monoclonal autoantibody is encoded by a variant V kappa II L chain gene. J Immunol 1991 0.80
46 2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med 1993 0.79
47 Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. Hum Gene Ther 1998 0.79
48 Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia. Blood 2001 0.79
49 Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Oncogene 1992 0.79
50 A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity. Cancer Immunol Immunother 2001 0.78
51 The effect of intraoperative ischemia on the recovery of contractile function after free muscle transfer. J Hand Surg Am 1988 0.77
52 Forced MyHCIIB expression following targeted genetic manipulation of conditionally immortalized muscle precursor cells. Exp Cell Res 1999 0.77
53 Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Ther 1997 0.77
54 A patient with progressive myelopathy and antibodies to human T-cell leukemia virus type I and human immunodeficiency virus type 1 in serum and cerebrospinal fluid. Arch Neurol 1990 0.76
55 Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for lymphomagenesis. Cancer Treat Res 2001 0.76
56 A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunol 1998 0.76
57 Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies. Cancer Chemother Pharmacol 2013 0.75
58 A comparative histochemical and morphometric study of canine skeletal muscle. Can J Vet Res 1989 0.75
59 Molecular characterization of HTLV-I infection in Israel. Ann N Y Acad Sci 1994 0.75
60 CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab. Am J Hematol 2000 0.75
61 Detection of human T-cell leukemia/lymphoma virus type I in a transfusion recipient with chronic myelopathy. Neurology 1989 0.75
62 Parathyroid hormone-related protein gene expression and human T cell leukemia virus-1 infection. Miner Electrolyte Metab 1995 0.75
63 Sequence analysis of the new human T cell leukemia/lymphoma virus type I isolate (HTLV-I) in Israel. Isr J Med Sci 1994 0.75
64 The role of the x gene in HTLV associated malignancy. Cancer Surv 1986 0.75
65 Elevated serum interleukin-2 receptors in a newly identified group with high rates of human T cell leukemia virus type I infection in Israel. J Infect Dis 1991 0.75
66 Fiber type morphometry and capillary geometry in free, vascularized muscle transfers. Microsurgery 1991 0.75
67 A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma. Hum Gene Ther 1998 0.75
68 Skeletal muscle fiber type, fiber size, and capillary supply in elite soccer players. Int J Sports Med 1990 0.75
69 Negative regulation of gene expression from the HTLV type II long terminal repeat by Rex: functional and structural dissociation from positive posttranscriptional regulation. AIDS Res Hum Retroviruses 1996 0.75